Short answer: the 525mg blend does not break down how much is ACV versus BHB, so dosages can't be verified against published research — a specific, disclosed gap named directly rather than glossed over.
Why the total figure alone isn't sufficient
Proprietary blend, amounts undisclosed — the 525mg total is published, but the ACV-to-BHB split is not — knowing the sum doesn't tell you how the two ingredient categories are actually proportioned.
Why this specifically prevents research comparison
Published research on ACV's glycemic effects or BHB's metabolic role typically studies specific, known amounts — without knowing this formula's actual split, you can't confirm it matches those studied doses.
What this means practically for your evaluation
No clinical trials on Gumitide's complete finished formula — combined with the undisclosed ratio, this reinforces that individual ingredient research doesn't fully confirm how this specific product performs.
Read the full transparency breakdown
What's disclosed, what isn't, named specifically.
Get Gumitide